Fine mapping and regulation of the association of p53 with p34(cdc2)

Oncogene

Volumn 16, Issue 1, 1998, Pages 105-111

  Wagner, Peter ^a   Fuchs, Annette ^a   Götz, Claudia ^a   Nastainczyk, Wolfgang ^a   Montenarh, Mathias ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Growth suppressor protein; p53; Protein kinase p34(cdc2)

Indexed keywords

ASPARTIC ACID; PROTEIN KINASE; PROTEIN P53; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; GENE MAPPING; GENETIC LINKAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

EID: 0032495575     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201510     Document Type: Article

References (49)

1. Appel K, Wagner P, Boldyreff B, Issinger OG and Montenarh M. (1995). Oncogene, 11, 1971-1978.
2. Bischoff JR, Friedman PN, Marshak DR, Prives C and Beach D. (1990). Proc. Natl. Acad. Sci. USA, 87, 4766-4770.
3. Chen J, Jackson PK, Kirschner MW and Dutta A. (1995). Nature, 374, 386-388.
4. Chen JJ, Peters R, Saha P, Lee P, Theodoras A, Pagano M, Wagner G and Dutta A. (1996). Nucleic Acids. Res., 24, 1727-1733.
5. Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E and Gronenborn AM. (1994). Science, 265, 386-391.
6. D'Amico D, Carbone D, Mitsudomi T, Nau M, Fedorko J, Russell E, Johnson B, Buchlagen D, Bodner S and Phelps R. (1992). Oncogene, 7, 339-346.
7. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 1169-1174.
8. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell 75, 817-825.
9. Fiscella M, Zambrano N, Ullrich SJ, Unger T, Lin D, Cho B, Mercer WE, Anderson CW and Appella E. (1994). Oncogene, 9, 3249-3257.
10. Fuchs B, Hecker D and Scheidtmann K-H. (1995). Eur. J. Biochem., 228, 625-639.
11. Hall SR, Campbell LE and Meek DW. (1996). Nucleic Acids. Res., 24, 1119-1126.
12. Harlow E, Crawford LV, Pim DC and Williamson NM. (1981). J. Virol., 398, 61-69.
13. Hartwell LH and Kastan MB. (1994). Science, 266, 1821-1828.
14. Hartwell LH and Weinert TA. (1989). Science, 246, 629-634.
15. Harvey DM and Levine AJ. (1991). Genes Dev., 5, 2375-2385.
16. Hecker D, Page G, Lohrum M, Weiland S and Scheidtmann KH. (1996). Oncogene, 12, 953-961.
17. Herrmann CPE, Kraiss S and Montenarh M. (1991). Oncogene, 6, 877-884.
18. Hupp TR and Lane DP. (1994). Current Biology 4, 865-875.
19. Hupp TR, Meek DW, Midgley CA and Lane DP. (1992). Cell, 71, 875-886.
20. Jacks T and Weinberg RA. (1996). Nature, 381, 643-644.
21. Kastan MB. (1993). Adv. Exp. Med. Biol., 339, 291-293.
22. Kraiss S, Barnekow A and Montenarh M. (1990). Oncogene, 5, 845-855.
23. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
24. Lane DP and Benchimol S. (1990). Genes Dev., 4, 1-8.
25. Lee JM and Bernstein A. (1993). Proc. Natl. Acad. Sci. USA, 90, 5742-5746.
26. Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. (1992). Mol. Cell. Biol., 12, 5041-5049.
27. Li B-L, Langer JA, Schwartz B and Pestka S. (1989). Proc. Natl. Acad. Sci. USA, 86, 558-562.
28. Liu F, Kohler MF, Marks JR, Bast RC, Boyd J and Berchuck A. (1994). Obstet. Gynecol., 83, 118-124.
29. Lorenz A, Herrmann CPE, Issinger O-G and Montenarh M. (1992). Int. J. Oncol., 1, 571-580.
30. Meek DW and Street AJ. (1992). Biochem. J., 287, 1-15.
31. Mercer WE, Shields MT, Lin D, Appella E and Ullrich SJ. (1991). Proc. Natl. Acad. Sci. USA, 88, 1958-1962.
32. Milne DM, Campbell DG, Caudwell FB and Meek DW. (1994). J. Biol. Chem., 269, 9253-9260.
33. Milne DM, Palmer RH, Campbell DG and Meek DW. (1992a). Oncogene, 7, 1361-1369.
34. Milne DM, Palmer RH and Meek DW. (1992b). Nucleic Acids. Res., 20, 5565-5570.
35. Milner J, Cook A and Mason J. (1990). EMBO J. 9, 2885-2889.
36. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H and Ishizaki K. (1993). Cancer Res., 53, 368-372.
37. Schneider E, Fuchs A, Nastainczyk W, Montenarh M and Wagner P. (1995). Hybridoma, 14, 329-333.
38. Selter H and Montenarh M. (1994). Int. J. Biochem., 26, 145-154.
39. Stürzbecher H-W, Maimets T, Chumakov P, Brain R, Addison C, Simanis V, Rudge K, Philp R, Grimaldi M, Court W and Jenkins JR. (1990). Oncogene, 5, 795-802.
40. Ullrich SJ, Sakaguchi K, Lees-Miller SP, Fiscella M, Mercer WE, Anderson CW and Appella E. (1993). Proc. Natl. Acad. Sci. USA, 90, 5954-5958.
41. Wagner P. (1994). Int. J. Oncol., 4, 987-992.
42. Wagner P, Appel K, Issinger OG and Montenarh M. (1994a). Int. J. Oncol., 4, 491-498.
43. Wagner P, Fuchs A and Nastainczyk W. (1995a). 7, 171-175.
44. Wagner P, Fuchs A, Prowald A, Montenarh M and Nastainczyk W. (1995b). FEBS Lett, 377, 155-158.
45. Wagner P, Grimaldi M and Jenkins JR. (1993). Eur. J. Biochem., 217, 731-736.
46. Wagner P, Simanis V, Maimets T, Keenan E, Addison C, Brain R, Grimaldi M, Stürzbecher HW and Jenkins J. (1991). Oncogene, 6, 1539-1547.
47. Wagner P, Waschow C, Nastainczyk W and Montenarh M (1994b). Hybridoma, 13, 527-529.
48. Waldman T, Lengauer C, Kinzler KW and Vogelstein B. (1996). Nature, 381, 713-716.
49. Wang Y and Prives C. ( 1995). Nature, 376, 88-91.